NL300354I2 - Gebruik van C22 tot C26 alifatische alcoholen bij de behandeling van ontstekingsziekten en virale ziekten van de huid - Google Patents

Gebruik van C22 tot C26 alifatische alcoholen bij de behandeling van ontstekingsziekten en virale ziekten van de huid

Info

Publication number
NL300354I2
NL300354I2 NL300354C NL300354C NL300354I2 NL 300354 I2 NL300354 I2 NL 300354I2 NL 300354 C NL300354 C NL 300354C NL 300354 C NL300354 C NL 300354C NL 300354 I2 NL300354 I2 NL 300354I2
Authority
NL
Netherlands
Prior art keywords
skin
aliphatic alcohols
inflammatory
treatment
viral diseases
Prior art date
Application number
NL300354C
Other languages
English (en)
Other versions
NL300354I1 (nl
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Publication of NL300354I1 publication Critical patent/NL300354I1/nl
Publication of NL300354I2 publication Critical patent/NL300354I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
NL300354C 1989-04-28 2008-06-05 Gebruik van C22 tot C26 alifatische alcoholen bij de behandeling van ontstekingsziekten en virale ziekten van de huid NL300354I2 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/345,084 US4874794A (en) 1989-04-28 1989-04-28 Inflammatory disease treatment

Publications (2)

Publication Number Publication Date
NL300354I1 NL300354I1 (nl) 2008-08-01
NL300354I2 true NL300354I2 (nl) 2008-10-01

Family

ID=23353439

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300354C NL300354I2 (nl) 1989-04-28 2008-06-05 Gebruik van C22 tot C26 alifatische alcoholen bij de behandeling van ontstekingsziekten en virale ziekten van de huid

Country Status (10)

Country Link
US (1) US4874794A (nl)
EP (1) EP0428642B1 (nl)
JP (1) JPH03505882A (nl)
AT (1) ATE95060T1 (nl)
DE (2) DE69003652T2 (nl)
DK (1) DK0428642T3 (nl)
ES (1) ES2060158T3 (nl)
HK (1) HK120497A (nl)
NL (1) NL300354I2 (nl)
WO (1) WO1990013216A2 (nl)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370871A (en) * 1983-01-24 1994-12-06 The Johns Hopkins University Therapeutic suppression of specific immune responses by administration of oligomeric forms of antigen of controlled chemistry
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
US5135956A (en) * 1988-10-18 1992-08-04 The Regents Of The University Of California Method of using cytoprotective alcohols to treat neural disease and neural injury
EP0448697B1 (fr) * 1989-10-13 1996-04-10 Neurofit Analogues de la vitamine a, leurs applications, notamment en tant que molecules cytotrophiques et cytoprotectrices, et compositions pharmaceutiques les contenant
US5214071A (en) * 1991-04-23 1993-05-25 Summit Technology, Inc. Corneal treatment agents
US5296514A (en) * 1991-04-23 1994-03-22 Summit Technology, Inc. Corneal treatment agents
US5098896A (en) * 1991-04-23 1992-03-24 Summit Technology, Inc. Corneal treatment agents
US5198217A (en) * 1991-09-24 1993-03-30 Choice Pharmaceuticals Topical demulcent for viral and inflammatory diseases of the skin
SG43833A1 (en) * 1993-12-13 1997-11-14 Lidak Pharmaceuticals Sucrose ester-c20 to c25 alcohol formulations
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5948822A (en) 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
US20050203187A1 (en) * 1998-06-01 2005-09-15 Verbiscar Anthony J. Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
ATE298345T1 (de) 1999-09-03 2005-07-15 Cabby Business Inc Effizientes verfahren zur herstellung sehr reiner sterinen
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
PT102410A (pt) * 2000-02-03 2001-08-30 Qualitas Lab Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico
ES2295149T3 (es) * 2000-04-12 2008-04-16 Liplasome Pharma A/S Sistemas de suministro de farmacos contra infecciones parasiticas.
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
BR0213323A (pt) * 2001-10-16 2005-01-25 Avanir Pharmaceuticals Inibição viral por n-docosanol
DE10203688A1 (de) 2002-01-31 2003-08-07 Bayer Cropscience Ag Synergistische insektizide Mischungen
DE10207242A1 (de) * 2002-02-21 2003-09-04 Bayer Cropscience Ag Synergistische insektizide Mischungen
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
WO2004037225A2 (en) 2002-10-25 2004-05-06 Foamix Ltd. Cosmetic and pharmaceutical foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
EP2422768B1 (en) 2003-08-25 2015-04-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
WO2007054818A2 (en) 2005-05-09 2007-05-18 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
US8470880B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
US9242923B2 (en) 2010-03-11 2016-01-26 Chemic Laboratories Inc. Compositons and methods
US8846725B2 (en) 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9675537B2 (en) 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
WO2017029647A1 (en) 2015-08-20 2017-02-23 Meir Eini Tetracycline management of egfr inhibitor associated dermatoses
US10561593B2 (en) 2015-12-28 2020-02-18 Johnson & Johnson Consumer Inc. Hair growth composition and method
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US20230346805A1 (en) 2019-07-31 2023-11-02 Journey Medical Corporation Compositions and methods and uses thereof
TW202135825A (zh) 2019-12-31 2021-10-01 美商維恩治療股份有限公司 含托法替尼（Ｔｏｆａｃｉｔｉｎｉｂ）之基於彈性體的無水凝膠調配物

Also Published As

Publication number Publication date
ATE95060T1 (de) 1993-10-15
DE69003652D1 (de) 1993-11-04
HK120497A (en) 1997-09-05
EP0428642B1 (en) 1993-09-29
WO1990013216A2 (en) 1990-11-15
DE122007000080I1 (de) 2008-02-28
US4874794A (en) 1989-10-17
NL300354I1 (nl) 2008-08-01
DE122007000080I2 (de) 2008-11-06
DE69003652T2 (de) 1994-03-24
ES2060158T3 (es) 1994-11-16
JPH03505882A (ja) 1991-12-19
EP0428642A1 (en) 1991-05-29
DK0428642T3 (da) 1994-02-21

Similar Documents

Publication Publication Date Title
NL300354I1 (nl) Gebruik van c22 tot c26 alifatische alcoholen bij de behandeling van ontstekingsziekten en virale ziekten van de huid
DE59108854D1 (de) Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
GB2276086A (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
DE59209735D1 (de) Durch Hitze und/oder Detergens virusinaktiviertes Blutprodukt
DE69312579T2 (de) Arzneimittel zur Behandlung von Vulva-Dystrophie oder Vaginaltrockenheit
DE3750934D1 (de) Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten.
DE3683333D1 (de) Mittel zur behandlung von akne vulgaris und deren herstellung.
IL94582A0 (en) Preparation for topical use containing depolymerized deoxyribonucleic acids to reduce unsightly defects of the epidermis of the face and some skin areas of the body
DE69426267D1 (de) Äusserlisches Hautbehandlungsmittel
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
DK137589D0 (da) Salicylsyreholdigt middel til behandling af hudsygdomme
ATE157530T1 (de) Mittel zur dauerhaften haarverformung
DE69004425D1 (de) Verwendung von c-20 bis c-26-aliphatischen alkoholen zur herstellung eines arzneimittels zur behandlung viraler infektionen.
SE8800990D0 (sv) Skin-regenerating cosmetic compositon and process for preparing same
DE3373978D1 (en) Composition for the care or treatment of the human skin
KR920011502A (ko) 인체 신경계의 통증을 치료할 수 있는 부자이중탕(附子理中湯)의 개량된 한방치료제 물질
KR960033315A (ko) 홍화(紅花)를 주재로한 건강음료의 제조방법
FR2406448A1 (fr) Produit cosmetique a base d'extraits de fucus et produisant un amincissement local
BG49742A1 (en) Affrodisiance means
ES2065086T3 (es) Procedimiento para la obtencion de aldehidos y cetonas alfa, beta-insaturados.
DE3868517D1 (de) Haarwuchsmittel.
KR960006930A (ko) 키위를 이용한 인체면역성 증진 및 인체질환 치료방법
FI941707A (fi) Naftokinoninen käyttö P. carinii -infektioiden hoitoon ja profylaksiaan
RU94005179A (ru) Средство для лечения больных очаговой склеродермией
HUT41255A (en) Desinfecting preparative mainly paste, emulsion or emulsion that can be performed to foam with skin protecting effect and process for production thereof